Filing Flows › Journey Medical (DERM) › How it makes money
How Journey Medical (DERM) makes money
Journey Medical (DERM) made $18.5M of revenue in the second quarter 2026 (Q2 2026), +23% from a year earlier. Emrosi brought in $8.1M (44%); Qbrexza brought in $5.1M (28%); Accutane brought in $3.4M (18%).
Drawing the Sankey…
Revenue by segment, Q2 2026
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Emrosi | $8.1M | 43.6% | — | +189% |
| Qbrexza | $5.1M | 27.6% | — | -26% |
| Accutane | $3.4M | 18.1% | — | -1% |
| Foam franchise products (Amzeeq & Zilxi) | $941K | 5.1% | — | -17% |
| Other revenues | $671K | 3.6% | — | — |
| Other / legacy | $232K | 1.3% | — | -68% |
| Eurax | $120K | 0.6% | — | — |
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $18.5M | 100.0% |
| Income tax | $15K | 0.1% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $18.5M | +23% |
| Q1 2026 | $16.0M | +22% |
| Q4 2025 | $16.1M | +18% |
| Q3 2025 | $17.6M | +20% |
| Q2 2025 | $15.0M | +1% |
| Q1 2025 | $13.1M | +0.8% |
| Q4 2024 | $13.6M | -11% |
From Journey Medical's 10-Q filed Aug 12, 2026 (on EDGAR).
Questions
How does Journey Medical make money?
Journey Medical (DERM) made $18.5M of revenue in the second quarter 2026 (Q2 2026), +23% from a year earlier. Emrosi brought in $8.1M (44%); Qbrexza brought in $5.1M (28%); Accutane brought in $3.4M (18%).
What is Journey Medical's biggest business?
Emrosi: $8.1M in the second quarter 2026, 44% of revenue, +189% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.